Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2013 / Article
Special Issue

Dietary Polyphenols and Their Effects on Cell Biochemistry and Pathophysiology 2013

View this Special Issue

Research Article | Open Access

Volume 2013 |Article ID 680816 | https://doi.org/10.1155/2013/680816

Marianna Guida, Tullia Maraldi, Elisa Resca, Francesca Beretti, Manuela Zavatti, Laura Bertoni, Giovanni B. La Sala, Anto De Pol, "Inhibition of Nuclear Nox4 Activity by Plumbagin: Effect on Proliferative Capacity in Human Amniotic Stem Cells", Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 680816, 12 pages, 2013. https://doi.org/10.1155/2013/680816

Inhibition of Nuclear Nox4 Activity by Plumbagin: Effect on Proliferative Capacity in Human Amniotic Stem Cells

Academic Editor: Cristina Angeloni
Received29 Jul 2013
Revised18 Nov 2013
Accepted19 Nov 2013
Published29 Dec 2013


Human amniotic fluid stem cells (AFSC) with multilineage differentiation potential are novel source for cell therapy. However, in vitro expansion leads to senescence affecting differentiation and proliferative capacities. Reactive oxygen species (ROS) have been involved in the regulation of stem cell pluripotency, proliferation, and differentiation. Redox-regulated signal transduction is coordinated by spatially controlled production of ROS within subcellular compartments. NAD(P)H oxidase family, in particular Nox4, has been known to produce ROS in the nucleus; however, the mechanisms and the meaning of this function remain largely unknown. In the present study, we show that Nox4 nuclear expression (nNox4) increases during culture passages up to cell cycle arrest and the serum starvation causes the same effect. With the decrease of Nox4 activity, obtained with plumbagin, a decline of nuclear ROS production and of DNA damage occurs. Moreover, plumbagin exposure reduces the binding between nNox4 and nucleoskeleton components, as Matrin 3. The same effect was observed also for the binding with phospho-ERK, although nuclear ERK and P-ERK are unchanged. Taken together, we suggest that nNox4 regulation may have important pathophysiologic effects in stem cell proliferation through modulation of nuclear signaling and DNA damage.

1. Introduction

Stem cells are characterized by a high capacity of self-renewal and differentiation. Through self-renewal, stem cells maintain the homeostasis of a stem cell pool; through differentiation, stem cells can give rise to terminal cells with diverse morphology and functions [1]. In tissues, most stem cells are in the quiescent state, and they are protected by special microenvironments (niches) [2]. The quiescence of stem cells may prevent the accumulation of DNA replication errors [3] and may facilitate resistance to many stressors [4]. The intracellular ROS level is a critical factor that regulates the quiescent status of mesenchymal stem cells (MSC) [5]. Similar to the low partial pressure of oxygen, low levels of ROS in niches are important for the stemness of MSC [6]. However, in vitro expansion of stem cells implies normoxic culture condition.

Indeed, MSC proliferative and colony formation capacity is significantly increased in normoxia. However, MSC expanded under normoxia show a threefold to fourfold increase in senescence, suggesting that hypoxia prevents oxidative stress-induced senescence and preserves MSC long-term self-renewal [7].

Accumulation of ROS is a common occurrence in senescent cells. Studies have shown that induction of ROS in senescent cells is involved in inhibiting proliferation [8]. On the other hand, intracellular accumulation of H2O2 in senescent human fetal MSCs termed placenta-derived multipotent cells (PDMCs) has been found, but the accumulation was not involved in inhibiting proliferation. Rather, H2O2 was involved in altering the differentiation potential of senescent PDMCs [9].

Various ROS-generating and ROS-degrading systems in different compartments of the cell seem to play an important role. The nucleus itself contains a number of proteins with oxidizable thiols that are essential for transcription, chromatin stability, and nuclear protein import and export, as well as DNA replication and repair [10]. Specific isoforms of glutathione peroxidases, glutathione S-transferases, and peroxiredoxins are enriched in nuclei, further supporting the interpretation that functions of the thiol-dependent systems in nuclei are at least quantitatively and probably also qualitatively distinct from similar processes in the cytoplasm [11].

ROS generation within the nucleus may have several important effects on cellular function. ROS can inactivate nuclear-localized phosphatases and thereby enhance kinase activation. For example, the oxidative inactivation of the nuclear phosphatase mitogen-activated kinase phosphatase 1 regulates ERK1/2 activation [12]. Excessive production of ROS could also lead to oxidative DNA damage.

In this point of view, the subcellular localization of NADPH oxidase isoform 4 (Nox4) is likely to be especially important, given its constitutive activity, unlike isoforms, such as Nox1 or Nox2, that requires agonist activation. However, its subcellular distribution remains controversial, at least in part attributable to the lack of sufficiently specific or characterized antibodies. Nox4 has been reported to be variably present in the ER [13, 14], mitochondria [15], cytoskeleton [16], plasma membrane [17], and nucleus [18] in different cell types.

Other unresolved questions include whether Nox4 utilizes NADPH or NADH as a substrate to produce [18, 19] and whether it primarily produces superoxide or hydrogen peroxide [18, 20].

More recently, endothelial nuclei have been shown to produce ROS that are, at least in part, Nox4 dependent [18, 21], but its subnuclear localization (within specific nuclear membranes) remains unclear [22]. Nuclear Nox4 has also been implicated in DNA damage resulting from both hemangioendothelioma formation [23] and hepatitis C infection [24].

NADPH oxidase Nox4 is a critical mediator in oncogenic H-RasV12-induced DNA damage response [25]. DNA damage response, detected by c-H2A.X foci analysis, leads to cell aging and subsequent senescence [26].

Anilkumar et al. [27] found that there is a nuclear-localized and functionally active splice variant of Nox4 (Nox4D) that may have important pathophysiologic effects through modulation of nuclear signaling and DNA damage. Interestingly, a significant proportion of nuclear Nox4D was localized to the nucleolus of vascular cells.

In this study, we investigated the role of Nox4-derived nuclear ROS on proliferative capacity of amniotic fluid stem cells (AFSC) since they can be considered representative of human stem cells, in view of their characteristics, such as the intermediate status between embryonic stem cells and adult stem cells.

Moreover, De Coppi and colleagues [28] described that AFSC can be directed into a wide range of cell types representing the three primary embryonic lineages of mesoderm, ectoderm, and definitive endoderm [29, 30]. Amniotic fluid is known to contain a heterogeneous population of cell types derived from fetal tissues and the amnion [31]. In vitro expansion of human stem cells is necessary to obtain a sufficient cell number to in vivo implant purpose, but it leads to senescence affecting proliferative and differentiation capacities. Thus, if the function of ROS is to enforce irreversible cellular senescence, the NADPH oxidase Nox4, as ROS-generating system, appears to be a potential nuclear ROS source.

Here, we show that a part of Nox4 localizes to the nucleus of AFSC, where the oxidase likely forms a functional complex with p22phox and produces ROS in the nucleoplasm. In addition, Nox4 seems to regulate DNA damage, constituting a part of oxidative stress. Here, we assessed the effect of plumbagin, a plant-derived naphthoquinone directly inhibiting Nox4 activity [32], on DNA damage and Nox4 nuclear interactions.

2. Materials and Methods

2.1. Cell Culture

Amniocentesis samples (5 back up flasks obtained from different donors) were provided by the Laboratorio di Genetica, Ospedale Santa Maria Nuova (Reggio Emilia, Italy). All samples were collected with informed consent of the patients (mother’s age 35) according to Italian law and ethical committee guideline.

Human AFSC were isolated as previously described by De Coppi et al. [28]. Human amniocentesis cultures were harvested by trypsinization and subjected to c-Kit immunoselection by MACS technology (Miltenyi Biotec, Germany). AFSC were subcultured routinely at 1 : 3 dilution and not allowed to expand beyond the 70% of confluence. AFSC were grown in culture medium (αMEM supplemented with 20% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin) (all from EuroClone Spa, Italy) [33].

Cells were treated with plumbagin (5-hydroxy-2-methyl-1,4 naphthoquinone) or diphenyleneiodonium (Sigma Aldrich, St. Louis, MO,USA).

2.2. Cell Viability and Proliferation Assay

Viable cells were evaluated by the MTT assay, since the reduction of tetrazolium salts is widely accepted as a reliable way to examine cell viability/proliferation. Cells were incubated with 0.5 mg/mL MTT for 4 h at 37°C, as previously reported [34]. At the end of the incubation, purple formazan salt crystals were dissolved by adding the solubilization solution (isopropanol, 0.01 M HCl). The absorption at 570 nm was measured on a multiwell plate reader (Appliskan, Thermo-Fisher Scientific, Vantaa, Finland).

2.3. Cell Cycle Analysis

For detection and quantification of cell cycle distribution, samples containing 2–5 105 cells were harvested by centrifugation, fixed in cold ethanol, and subjected to propidium iodide (Sigma Aldrich, St. Louis, MO, USA) flow cytometric assay. Total lysates, obtained as reported below, were subjected to Western blotting and revealed for anticyclin E (Santa Cruz Biotechnology, Santa Cruz, CA, USA).

2.4. Preparation of Cell Extracts

Cell extracts were obtained as described by Maraldi et al. [35]. Briefly, subconfluent cells were extracted by addition of AT lysis buffer (20 mM Tris-Cl, pH 7.0; 1% nonidet P-40; 150 mM NaCl; 10% glycerol; 10 mM EDTA; 20 mM NaF; 5 mM sodium pyrophosphate; and 1 mM Na3VO4) and freshly added Sigma Aldrich protease inhibitor cocktail at 4°C for 30 min. Lysates were sonicated, cleared by centrifugation, and immediately boiled in SDS sample buffer or used for immunoprecipitation experiments, as described below.

2.5. Immunoprecipitation and Electrophoresis

Immunoprecipitation was performed as reported by Cenni et al. [36]. Equal amounts of precleared lysates, whose protein concentration was determined by the Bradford method, were incubated overnight with anti-NOX4 (Novus Biologicals, CO, USA), antipan 14.3.3 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) (3 μg all). Then, the two samples were treated with 30 μL of 50% (v/v) of protein A/G agarose slurry (GE Healthcare Bio-sciences, Uppsala, Sweden) at 4°C with gentle rocking for 1 h. Pellets were washed twice with 20 mM Tris-Cl, pH 7.0; 1% Nonidet P-40; 150 mM NaCl; 10% glycerol; 10 mM EDTA; 20 mM NaF; and 5 mM sodium pyrophosphate and once with 10 mM Tris-Cl, pH 7.4, boiled in SDS sample buffer, and centrifuged. Supernatants were loaded onto SDS-polyacrylamide gel, blotted on Immobilon-P membranes (Millipore, Waltham, MA, USA), and processed by Western blot with the indicated antibodies, detected by Supersignal substrate chemiluminescence detection kit (Pierce, Rockford, IL, USA). Quantitation of the signal was obtained by chemiluminescence detection on a Kodak Image Station 440CF and analysis with the Kodak 1D Image software.

2.6. Nuclei Purification

Human AFSC nuclei were purified as reported by Cenni et al. [37]. Briefly, to 5 × 106 cells 400 μL of nuclear isolation buffer was added (10 mM Tris-HCl, pH 7.8, 1% Nonidet P-40, 10 mM β-mercaptoethanol, 0.5 mM phenylmethylsulfonyl fluoride, 1 μg/mL aprotinin and leupeptin, and 5 mM NaF) for 8 min on ice. MilliQ water (400 μL) was then added to swell cells for 3 min. Cells were sheared by passages through a 22-gauge needle. Nuclei were recovered by centrifugation at 400 ×g at 4°C for 6 min and washed once in 400 μL of washing buffer (10 mM Tris-HCl, pH 7.4, and 2 mM MgCl2, plus inhibitors as described earlier in the text). Supernatants (containing the cytosolic fractions) were further centrifuged for 30 min at 4000 ×g. Isolated nuclear and cytoplasmic extracts were finally lysed in AT lysis buffer, sonicated, and cleared by centrifugation.

2.7. Western Blot

The protocols of the western blot were performed as described by Hanson et al. [38].

Protein extracts, quantified by a Bradford Protein Assay (Bio-Rad Laboratories, CA, USA), underwent to SDS-polyacrylamide gel electrophoresis and were transferred to Immobilon-P membranes. The following antibodies were used: rabbit antipan 14.3.3, rabbit anticyclin E, rabbit anti-Nox4, rabbit anti-Ki67, Rabbit anti-ERK1/2, goat anti-Matrin 3, goat anti-actin, anti-p22phox (Santa Cruz Biotechnology, Santa Cruz, CA, USA) diluted 1 : 500, rabbit anti-p44/42 ERK1/2 (Cell Signalling Technology, Beverly, MA, USA), mouse anti-Tubulin (Sigma Aldrich St. Louis, MO, USA), rabbit anti-Nox4 (Abcam, Cambridge, UK), rabbit anti-Nox4 (Novus Biologicals, CO, USA), and mouse anti-pH2A (Ser139) (Millipore, Billerica, MA, USA) diluted 1 : 1000; peroxidase-labelled anti-rabbit, mouse, and goat secondary antibodies diluted 1 : 3000 (Pierce Antibodies, Thermo Scientific; Rockford, IL, USA). Ab dilution was performed in TBS-T pH 7.6 containing 3% BSA. The membranes were visualized using Supersignal substrate chemiluminescence detection kit (Pierce, Rockford, IL, USA). Antiactin antibody was used as control of protein loading.

2.8. Confocal Microscopy

Undifferentiated AFSC were fixed for 20 min in 4% ice-cold paraformaldehyde and then permeabilized with 0.1% Triton X-100 in ice-cold phosphate-buffered saline (PBS) for 5 min. Permeabilized samples were then blocked with 3% of bovine serum albumin (BSA) in PBS for 30 min at room temperature and incubated with primary antibodies (Abs). Rabbit anti-Nox4, goat anti-Matrin 3, rabbit anti-Ki67 (Santa Cruz, CA, USA) (diluted 1 : 50), and mouse anti-pH2A (Ser139) (Millipore, Billerica, MA, USA) (diluted 1 : 100), in PBS containing 3% BSA for 1 h at RT were used as primary antibodies (Ab). Secondary Ab was diluted 1 : 200 in PBS containing 3% BSA (goat anti-mouse Alexa 647, goat anti-rabbit Alexa 488, and donkey anti-goat Alexa 488). After washing in PBS, samples were stained with 1 μg/mL DAPI in H2O for 1 min and then mounted with antifading medium (0.21 M DABCO and 90% glycerol in 0.02 M Tris, pH 8.0). Negative controls consisted of samples not incubated with the primary antibody, but only with the secondary antibody.

Confocal imaging was performed on a Nikon A1 confocal laser scanning microscope as previously described [39].

Spectral analysis was carried out to exclude overlapping between two signals or the influence of autofluorescence background on the fluorochrome signals, as previously shown [40]. The confocal serial sections were processed with ImageJ software to obtain three-dimensional projections, as previously described [41]. The image rendering was performed by Adobe Photoshop software.

2.9. Nuclear ROS Imaging

Nuclear ROS were detected with nuclear-localized fluorescent probe for H2O2, Nuclear Peroxy Emerald 1 (NucPE1) [4245]. For all experiments, 5 μM solutions of NucPE1 (from 5 mM stocks in DMSO) were made in PBS/glucose. The cells were then kept in an incubator (37°C, 5% CO2) during the course of all experiments. The probes were incubated for total 30 min. Fluorescence was measured on a multiwell plate reader (Appliskan, Thermo Scientific) using 488 nm filter for excitation and 535 nm filter for emission.

Confocal fluorescence imaging studies were performed with a Nikon A1 confocal laser scanning microscope. Excitation of NucPE1-loaded cells at 488 nm was carried out with an Ar laser and emission was collected at 535 nm. All images in an experiment were collected simultaneously using identical microscope settings. Image analysis was performed in Image J.

2.10. Statistical Analysis

In vitro experiments were performed in triplicate. For quantitative comparisons, values were reported as mean ± SD based on triplicate analysis for each sample. To test the significance of observed differences between the study groups, unpaired Student’s t-test was applied. A value < 0.05 was considered to be statistically significant.

3. Results and Discussion

3.1. Nox4 Expression in AFSC

At first we noticed that amniotic fluid stem cells express NADPH isoform 4 Nox4 both into the nucleus and in the cytoplasm, unlike Nox1 and Nox2 (data not shown). We tested different antibodies directed to Nox4 protein in order to verify this observation. In fact, in the literature, a homemade antibody anti-Nox4 is often used (polyclonal Nox4 antibodies by the Lambeth and Shah groups are the most frequently used) (see review [46]). On the other hand, all the employed antibodies revealed a variable percentage of cells with a nuclear localization of Nox4 (Figure 1(a)) and this data is consistent with other studies in which Nox4 has been found in nuclear or perinuclear area [18, 25, 47, 48]. By using antibodies from Santa Cruz, Abcam, or Novus, we can see a signal mostly localized inside the nuclei, not in the nuclear envelope, as demonstrated in mouse liver cells [48]. Regarding the staining obtained with Abcam antibody, all the nucleoplasm is marked except for nucleoli. Novus antibody binds other perinucleolar domains, while Santa Cruz antibody shows a more punctate pattern.

In order to investigate the NADPH oxidase activity inside nuclei, we used a nuclear selective probe for H2O2, nuclear Peroxy Emerald 1 (Figure 1(b)). Detection of nuclear ROS production with this probe demonstrates that ROS sources inside the nuclei have a punctate pattern similar to the one of Nox4 from Santa Cruz. Therefore, for immunofluorescence analysis, we utilized this antibody.

The same analysis has been performed for Western blot experiments (Figure 2(a)). Total lysates, cytosol, and nuclear fractions and the three antibodies reported above were tested.

WB analysis with all the antibodies of nuclear and cytoplasmic fractions confirms Nox4 presence both in cytosol and nuclei. Incubation with all the three antibodies reveals a triple band between 50 and 75 kDa, even if the band intensity is different depending on the antibody. In WB, the antibody from Novus seems to recognize the nuclear Nox4 (nNox4) better than others, since the bands in nuclear protein fraction are the most intense (Figure 2(a)).

The Novus antibody works also in immunoprecipitation experiment. Figure 2(b) shows nuclear extracts (NL) used for coimmunoprecipitation analysis with anti-Nox4 (IPNox4). This experiment confirms the presence of Nox4 in nuclear proteins showing the interaction between Nox4 and the modulatory subunit p22phox. Furthermore, Nox4 seems to be linked with nuclear matrix protein, Matrin3, and with the mitogen-activated protein kinase ERK1/2, suggesting a direct role in nuclear MAPK signaling regulation. It has been previously demonstrated that ERK activation (phosphorylation) occurs downstream from the Nox4 pathway: in particular through the Ras activation in endoplasmic reticulum of Human umbilical vein endothelial cells [49] or by a Src/caveolin-mediated activation in renal tubular cells [50].

3.2. Modulation of Nox4 Presence into the Nuclei

The ERK cascade is involved in cellular proliferation, differentiation, and survival. In fact nuclear translocation of ERK1 and ERK2 is critical for both gene expression and DNA replication induced by growth factors [51]. Moreover, in the nucleus, ERK phosphorylates an array of targets, including transcription factors involved in multiple aspects of growth control. Based on these considerations, we investigated the effect of proliferation stimuli on Nox4 localization in AFSC. AFSC are usually grown in the presence of 20% serum in order to induce the best proliferation rate. Serum starvation (−FBS) in fact affects Nox4 distribution within the cell. As demonstrated by WB and IF analysis shown in Figures 3(a) and 3(b), the nuclear portion of Nox4 (nNox4) increases in AFSC cultured without FBS for 24 hours. In fact, confocal images show the Nox4 punctate pattern in the majority of nuclei in–FBS sample. Serum deprivation induces also a decrease in Nox4 staining in the cytosol (Figures 3(a) and 3(b)), compared to +FBS sample.

This observation is consistent with data obtained with the fluorogenic probe assay for nuclear ROS. In fact the number of nuclei strongly stained with the probe is higher in culture −FBS (Figure 3(c)). The nuclear ROS quantification shows that the increase of fluorescence intensity in the absence of FBS is around 50%.

Amniotic fluid stem cells, after a week of slow proliferation in culture, can be passaged at 70% confluence every two to three days. As mesechymal stem cells, they can rapidly react to changes of the culture environment during expansion. In particular, MSC have been proved to gradually become senescent and decrease their proliferative capacity while in culture. The proliferation curve of AFSC in our experimental condition is shown in Figure 4(a), where the percentage of cells in S phase is graphed. After the first 3-4 passages of slow growth, an increase in proliferation occurs up to a plateau state around the 8th passage; hence, the number of cells able to divide decreases quickly.

Western blot analysis of AFSC during late passages (Figure 4(b)) shows that nuclear Nox4 presence dramatically increases at cell cycle arrest, decreasing the cytosol. Indeed confocal images show the Nox4 punctate pattern in the majority of nuclei in sample at 12th passage. In fact, while Cyclin E expression decreases at 12th passage, indicating a stop in proliferation, Nox4 raises in nuclear fraction. The same trend can be observed by IF analysis, as shown in Figure 4(c).

3.3. Effect of Nox4 Inhibition on AFSC Proliferation

In order to evaluate the effects of Nox4 inhibition on cell viability/proliferation, we used plumbagin, a plant-derived naphthoquinone, directly interacting with Nox4 and inhibiting its activity [31]. MTT test shows that 1-2 μM plumbagin does not affect negatively cell viability, but rather, at 2 μM concentration plumbagin is able to significantly improve cell proliferation. At higher concentrations, plumbagin decreases AFSC viability around 50–60% after 1 day of incubation (Figure 5(a)); therefore, these concentrations were not chosen for the reported experiments.

Moreover, late passages (8–12 p) AFSC cultured in the presence of 2 μM plumbagin display a better proliferation trend, as shown in graph of phase S cells (Figure 5(b)), even if not always in a significant manner. The same indication is provided by IF experiment of Ki-67 staining during culture passages (Figure 5(c)). The expression of the human Ki-67 protein is strictly associated with cell proliferation. The number of nuclei positive for Ki-67 is dramatically reduced in sample of late passage. In the presence of plumbagin, the staining of Ki-67 is higher both at 8th and 12th passages, compared to control samples.

Even if the use of Nox4 synthetic or natural inhibitors, diphenyleneiodonium (DPI) and Plumbagin, is not directed to the nuclear part of Nox4, as demonstrated by the fluorogenic probe assay, the Nox4 activity inhibition reduces the nuclear ROS production (Figure 6(a)). The nuclear ROS quantification shows that the decrease of fluorescence intensity in the presence of DPI or plumbagin is around 50% for both. This effect can regulate cell proliferation also through a modulation of DNA stability. In fact, ROS can also activate both cell survival and senescence pathways depending on its concentration and localization [5254]. To assess whether nNox4-generated ROS can induce nuclear DNA damage, we studied nuclear H2A foci. It has been shown recently that the status of H2AX phosphorylation is crucial to determine whether cells will survive after DNA damage [55].

The ROS production decrease, obtained with synthetic or natural Nox4 inhibitors (DPI and Plumbagin), reduces the staining for the phosphorylated form of histone H2AX, marker of oxidative stress derived-DNA damage (Figure 6(b)).

3.4. Effect of Plumbagin on Nox4 Nuclear Interaction

We investigated the effect of Nox4 inhibition on the previously observed nuclear Nox4 binding network (Figure 2(b)). The Nox4-derived ROS decrease, obtained with DPI or plumbagin incubated for 24 hours, reduces the expression of ERK in total lysates, but the P-ERK level remains unchanged (Figure 7(a)). Coimmunoprecipitation experiment for Nox4 shows that, in the presence of plumbagin, Nox4 binding with P-ERK decreases (Figure 7(b)). This data confirms the link between Nox4 and ERK1/2 within the nucleus, as shown also in VSMC where Nox4 specifically increased nuclear phosphorylated ERK1/2 [27] but emphasizes the direct association and the modulation of this nuclear kinase in the active form by the ROS source, Nox4.

Also the interaction with some nucleoskeleton molecules seems to be modulable by Nox4 inhibition. In fact, CoIP for Nox4 shows a decrease in matrin 3 binding in sample treated with plumbagin (Figure 7(b)). Matrin 3, an abundant protein of the internal nuclear matrix, has been linked to a variety of functional events. While many sites occurred proximal to nucleoli, no significant staining was detected within the nucleolar interior. On the other hand, matrin 3 has been demonstrated to bind DNA at sites termed scaffold/matrix attachment regions to regulate gene expression through interactions with chromatin remodeling. Matrin 3 has been involved also in transcriptome machinery through RNA processing and structural organization [56]. Matrin 3 could be a docking site where nuclear ROS signaling may exert its function on transcription/pre-mRNA modulation in specific nuclear domains.

14-3-3 proteins have the ability to bind a multitude of functionally diverse signaling proteins, including kinases, phosphatases, playing important roles in a wide range of vital regulatory processes, such as mitogenic signal transduction and cell cycle control.

There are common themes by which 14-3-3 proteins regulate different signaling pathways. 14-3-3 can control the location of proteins by preventing nuclear import/export or membrane translocation or both. Moreover, 14-3-3 may compete with other signaling proteins for binding on the target protein and may modulate its substrate from ubiquitination and degradation [57].

The effect of Nox4 activity inhibition by plumbagin could cause a Nox4 sequestration by 14-3-3 binding, as shown by CoIP experiment for 14-3-3 (Figure 7(c)). In fact, a longer incubation (72 h) with plumbagin induces a decrease in Nox4 presence inside nuclei, while matrin 3 pattern is unchanged (Figure 7(d)). Indeed, the image shows the double staining for matrin3 (green) and Nox4 (red). In the control case, the superimposing produces an orange staining, indicating the presence of high red signal, while in the sample with plumbagin the superimposing causes only a green staining, due to the anti-Matrin 3 labeling.

4. Conclusions

We observed that Nox4 isoform is expressed in human AFSC and, interestingly, it localizes into the nucleus. Confocal analysis demonstrates Nox4 presence in nucleoplasm domains, not only in nuclear membranes, suggesting that Nox4 could be involved in regulating DNA-mRNA processing machinery by ROS production in specific nuclear area. During culture passages up to cell cycle arrest, AFSC exhibit a proliferation rate inversely coupled with Nox4 presence into the nuclei. Furthermore, the serum starvation causes the same effect. Moreover, immunoprecipitation analysis demonstrated that Nox4 interacts with ERK signaling, suggesting a role in nuclear signaling pathways.

Inhibition of Nox4 activity, obtained with plumbagin, induces a decline of nuclear ROS production and of DNA damage. Moreover, plumbagin exposure reduces the binding between nNox4 nucleoskeleton components. The same effect was observed also for the binding with phospho-ERK, although nuclear ERK and P-ERK are unchanged. A longer incubation with plumbagin may modulate Nox4 nuclear expression, by controlling the protein localization or/and a degradation pathway involvement. Taken together, we suggest that nNox4 regulation may have important pathophysiologic effects in stem cell proliferation through modulation of nuclear signaling and DNA damage.


AFSC:Amniotic fluid stem cells
BSA:Bovine serum albumin
EDTA:Ethylenediaminetetraacetic acid
MSCs:Mesenchymal stem cells
PBS:Phosphate buffered saline
TBS:Tris-buffered saline

Conflict of Interests

The authors report no conflict of interests.

Authors’ Contribution

Marianna Guida prepared in vitro culture and carried out almost all the experiment; Tullia Maraldi designed the experiment, carried out experiments, and drafted the paper; Elisa Resca participated in IF experiments; Francesca Beretti carried out IP experiments; Manuela Zavatti carried out statistical analysis; Laura Bertoni participated in the analysis of all the experiments; Giovanni B. La Sala collected amniotic fluids and the informed consents of patients; Anto De Pol participated in drafting the manuscript.


The authors thank Dr. Fabrizia Franchi (Laboratorio di Genetica, Ospedale Santa Maria Nuova, Viale Risorgimento, 80, 42100 Reggio Emilia, Italy) for providing samples of amniotic fluid cells and thank Dr. Christopher J. Chang and Dr. Bryan C. Dickinson, Department of Chemistry, The University of California, Berkeley, CA, USA, for gently providing Nuclear peroxy Emerald 1. This work was supported by grants from MIUR PRIN 2009 Prot: 200938XJLA_002 and MIUR FIRB Accordi di Programma 2010 Prot: RBAP10Z7FS.


  1. X. Shi, Y. Zhang, J. Zheng, and J. Pan, “Reactive oxygen species in cancer stem cells,” Antioxidants and Redox Signaling, vol. 16, no. 11, pp. 1215–1228, 2012. View at: Publisher Site | Google Scholar
  2. S. J. Morrison and A. C. Spradling, “Stem cells and niches: mechanisms that promote stem cell maintenance throughout life,” Cell, vol. 132, no. 4, pp. 598–611, 2008. View at: Publisher Site | Google Scholar
  3. F. Arai, A. Hirao, M. Ohmura et al., “Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche,” Cell, vol. 118, no. 2, pp. 149–161, 2004. View at: Publisher Site | Google Scholar
  4. K. Ito, R. Bernardi, A. Morotti et al., “PML targeting eradicates quiescent leukaemia-initiating cells,” Nature, vol. 453, no. 7198, pp. 1072–1078, 2008. View at: Publisher Site | Google Scholar
  5. Z. Tothova, R. Kollipara, B. J. Huntly et al., “FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress,” Cell, vol. 128, no. 2, pp. 325–339, 2007. View at: Publisher Site | Google Scholar
  6. Y.-Y. Jang and S. J. Sharkis, “A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche,” Blood, vol. 110, no. 8, pp. 3056–3063, 2007. View at: Publisher Site | Google Scholar
  7. G. Pattappa, S. D. Thorpe, N. C. Jegard, H. K. Heywood, J. D. de Bruijn, and D. A. Lee, “Continuous and uninterrupted oxygen tension influences the colony formation and oxidative metabolism of human mesenchymal stem cells,” Tissue Engineering C, vol. 19, no. 1, pp. 68–79, 2013. View at: Publisher Site | Google Scholar
  8. J. Dai, X. Zhu, M. C. Yoder, Y. Wu, and R. W. Colman, “Cleaved high-molecular-weight kininogen accelerates the onset of endothelial progenitor cell senescence by induction of reactive oxygen species,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 4, pp. 883–889, 2011. View at: Publisher Site | Google Scholar
  9. P. J. Ho, M. L. Yen, B. C. Tang, C. T. Chen, and B. L. Yen, “H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells,” Antioxid Redox Signal, vol. 18, no. 15, pp. 1895–1905, 2013. View at: Publisher Site | Google Scholar
  10. T. Kietzmann, “Intracellular redox compartments: mechanisms and significances,” Antioxidants & Redox Signaling, vol. 13, no. 4, pp. 395–398, 2010. View at: Publisher Site | Google Scholar
  11. Y.-M. Go and D. P. Jones, “Redox control systems in the nucleus: mechanisms and functions,” Antioxidants & Redox Signaling, vol. 13, no. 4, pp. 489–509, 2010. View at: Publisher Site | Google Scholar
  12. R.-M. Liu, J. Choi, J.-H. Wu et al., “Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor β1-induced expression of plasminogen activator inhibitor 1 in fibroblasts,” The Journal of Biological Chemistry, vol. 285, no. 21, pp. 16239–16247, 2010. View at: Publisher Site | Google Scholar
  13. K. Chen, M. T. Kirber, H. Xiao, Y. Yang, and J. F. Keaney Jr., “Regulation of ROS signal transduction by NADPH oxidase 4 localization,” The Journal of Cell Biology, vol. 181, no. 7, pp. 1129–1139, 2008. View at: Publisher Site | Google Scholar
  14. R. K. Ambasta, P. Kumar, K. K. Griendling, H. H. Schmidt, R. Busse, and R. P. Brandes, “Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase,” The Journal of Biological Chemistry, vol. 279, no. 44, pp. 45935–45941, 2004. View at: Publisher Site | Google Scholar
  15. K. Block, Y. Gorin, and H. E. Abboud, “Subcellular localization of Nox4 and regulation in diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14385–14390, 2009. View at: Publisher Site | Google Scholar
  16. L. L. Hilenski, R. E. Clempus, M. T. Quinn, J. D. Lambeth, and K. K. Griendling, “Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 677–683, 2004. View at: Publisher Site | Google Scholar
  17. Y.-M. Lee, B.-J. Kim, Y.-S. Chun et al., “NOX4 as an oxygen sensor to regulate TASK-1 activity,” Cellular Signalling, vol. 18, no. 4, pp. 499–507, 2006. View at: Publisher Site | Google Scholar
  18. J. Kuroda, K. Nakagawa, T. Yamasaki et al., “The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells,” Genes to Cells, vol. 10, no. 12, pp. 1139–1151, 2005. View at: Publisher Site | Google Scholar
  19. P. Wang, F. Tang, R. Li et al., “Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan,” Pharmacological Research, vol. 55, no. 5, pp. 408–417, 2007. View at: Publisher Site | Google Scholar
  20. S. I. Dikalov, A. E. Dikalova, A. T. Bikineyeva, H. H. Schmidt, D. G. Harrison, and K. K. Griendling, “Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production,” Free Radical Biology and Medicine, vol. 45, no. 9, pp. 1340–1351, 2008. View at: Publisher Site | Google Scholar
  21. S. Pendyala, I. A. Gorshkova, P. V. Usatyuk et al., “Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells,” Antioxidants and Redox Signaling, vol. 11, no. 4, pp. 747–764, 2009. View at: Publisher Site | Google Scholar
  22. A. N. Lyle, N. N. Deshpande, Y. Taniyama et al., “Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells,” Circulation Research, vol. 105, no. 3, pp. 249–259, 2009. View at: Publisher Site | Google Scholar
  23. G. Gordillo, H. Fang, H. Park, and S. Roy, “Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation,” Antioxidants and Redox Signaling, vol. 12, no. 8, pp. 933–943, 2010. View at: Publisher Site | Google Scholar
  24. N. S. De Mochel, S. Seronello, S. H. Wang et al., “Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection,” Hepatology, vol. 52, no. 1, pp. 47–59, 2010. View at: Publisher Site | Google Scholar
  25. U. Weyemi and C. Dupuy, “The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses,” Mutation Research, vol. 751, no. 2, pp. 77–81, 2012. View at: Publisher Site | Google Scholar
  26. G. Lattanzi, S. Marmiroli, A. Facchini, and N. M. Maraldi, “Nuclear damages and oxidative stress: new perspectives for laminopathies,” European Journal of Histochemistry, vol. 56, no. 4, article e45, 2012. View at: Publisher Site | Google Scholar
  27. N. Anilkumar, G. S. Jose, I. Sawyer et al., “A 28-kDa splice variant of NADPH oxidase-4 is nuclear-localized and involved in redox signaling in vascular cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 4, pp. e104–e112, 2013. View at: Publisher Site | Google Scholar
  28. P. De Coppi, G. Bartsch Jr., M. M. Siddiqui et al., “Isolation of amniotic stem cell lines with potential for therapy,” Nature Biotechnology, vol. 25, no. 1, pp. 100–106, 2007. View at: Publisher Site | Google Scholar
  29. T. Maraldi, M. Riccio, A. Pisciotta et al., “Human amniotic fluid-derived and dental pulp-derived stem cells seeded into collagen scaffold repair critical-size bone defects promoting vascularization,” Stem Cell Research & Therapy, vol. 4, no. 3, article 53, 2013. View at: Publisher Site | Google Scholar
  30. G. Carnevale, M. Riccio, A. Pisciotta et al., “In vitro differentiation into insulin-producing β-cells of stem cells isolated from human amniotic fluid and dental pulp,” Digestive and Liver Disease, vol. 45, no. 8, pp. 669–676, 2013. View at: Publisher Site | Google Scholar
  31. A. Trounson, “A fluid means of stem cell generation,” Nature Biotechnology, vol. 25, no. 1, pp. 62–63, 2007. View at: Publisher Site | Google Scholar
  32. Y. Ding, Z.-J. Chen, S. Liu, D. Che, M. Vetter, and C.-H. Chang, “Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone,” Journal of Pharmacy and Pharmacology, vol. 57, no. 1, pp. 111–116, 2005. View at: Publisher Site | Google Scholar
  33. M. Zavatti, E. Resca, L. Bertoni et al., “Ferutinin promotes proliferation and osteoblastic differentiation in human amniotic fluid and dental pulp stem cells,” Life Sciences, vol. 92, no. 20-21, pp. 993–1003, 2013. View at: Publisher Site | Google Scholar
  34. T. Maraldi, M. Riccio, L. Zambonin, M. Vinceti, A. De Pol, and G. Hakim, “Low levels of selenium compounds are selectively toxic for a human neuron cell line through ROS/RNS increase and apoptotic process activation,” NeuroToxicology, vol. 32, no. 2, pp. 180–187, 2011. View at: Publisher Site | Google Scholar
  35. T. Maraldi, J. Bertacchini, M. Benincasa et al., “Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia,” International Journal of Oncology, vol. 38, no. 2, pp. 427–435, 2011. View at: Publisher Site | Google Scholar
  36. V. Cenni, J. Bertacchini, F. Beretti et al., “Lamin A Ser404 Is a nuclear target of akt phosphorylation in C2C12 cells,” Journal of Proteome Research, vol. 7, no. 11, pp. 4727–4735, 2008. View at: Publisher Site | Google Scholar
  37. V. Cenni, A. Bavelloni, F. Beretti et al., “Ankrd2/ARPP is a novel Akt2 specific substrate and regulates myogenic differentiation upon cellular exposure to H2O2,” Molecular Biology of the Cell, vol. 22, no. 16, pp. 2946–2956, 2011. View at: Publisher Site | Google Scholar
  38. C. J. Hanson, M. D. Bootman, C. W. Distelhorst, T. Maraldi, and H. L. Roderick, “The cellular concentration of Bcl-2 determines its pro- or anti-apoptotic effect,” Cell Calcium, vol. 44, no. 3, pp. 243–258, 2008. View at: Publisher Site | Google Scholar
  39. E. Resca, M. Zavatti, L. Bertoni et al., “Enrichment in c-Kit+ enhances mesodermal and neural differentiation of human chorionic placental cells,” Placenta, vol. 34, no. 7, pp. 526–535, 2013. View at: Publisher Site | Google Scholar
  40. A. Pisciotta, M. Riccio, G. Carnevale et al., “Human serum promotes osteogenic differentiation of human dental pulp stem cells in vitro and in vivo,” PLoS One, vol. 7, no. 11, Article ID e50542, 2012. View at: Publisher Site | Google Scholar
  41. M. Riccio, E. Resca, T. Maraldi et al., “Human dental pulp stem cells produce mineralized matrix in 2D and 3D cultures,” European Journal of Histochemistry, vol. 54, no. 4, article 46, 2010. View at: Google Scholar
  42. B. C. Dickinson, Y. Tang, Z. Chang, and C. J. Chang, “A nuclear-localized fluorescent hydrogen peroxide probe for monitoring sirtuin-mediated oxidative stress responses in vivo,” Chemistry and Biology, vol. 18, no. 8, pp. 943–948, 2011. View at: Publisher Site | Google Scholar
  43. A. R. Lippert, G. C. Van De Bittner, and C. J. Chang, “Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems,” Accounts of Chemical Research, vol. 44, no. 9, pp. 793–804, 2011. View at: Publisher Site | Google Scholar
  44. V. S. Lin, B. C. Dickinson, and C. J. Chang, “Boronate-based fluorescent probes: imaging hydrogen peroxide in living systems,” Methods in Enzymology, vol. 526, pp. 19–43, chapter 2 in Hydrogen Peroxide and Cell Signaling, Part A, 2013. View at: Publisher Site | Google Scholar
  45. B. C. Dickinson and C. J. Chang, “Chemistry and biology of reactive oxygen species in signaling or stress responses,” Nature Chemical Biology, vol. 7, no. 8, pp. 504–511, 2011. View at: Publisher Site | Google Scholar
  46. S. Altenhöfer, P. W. Kleikers, K. A. Radermacher et al., “The NOX toolbox: validating the role of NADPH oxidases in physiology and disease,” Cellular and Molecular Life Sciences, vol. 69, no. 14, pp. 2327–2343, 2012. View at: Publisher Site | Google Scholar
  47. K. D. Pendergrass, T. M. Gwathmey, R. D. Michalek, J. M. Grayson, and M. C. Chappell, “The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus,” Biochemical and Biophysical Research Communications, vol. 384, no. 2, pp. 149–154, 2009. View at: Publisher Site | Google Scholar
  48. N. Y. Spencer, Z. Yan, R. L. Boudreau et al., “Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4,” The Journal of Biological Chemistry, vol. 286, no. 11, pp. 8977–8987, 2011. View at: Publisher Site | Google Scholar
  49. R.-F. Wu, Z. Ma, Z. Liu, and L. S. Terada, “Nox4-derived H2O2 mediates endoplasmic reticulum signaling through local ras activation,” Molecular and Cellular Biology, vol. 30, no. 14, pp. 3553–3568, 2010. View at: Publisher Site | Google Scholar
  50. J. Chen, J.-K. Chen, and R. C. Harris, “Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway,” Molecular and Cellular Biology, vol. 32, no. 5, pp. 981–991, 2012. View at: Publisher Site | Google Scholar
  51. K. J. Schmitz, H. Lang, J. Wohlschlaeger et al., “AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma,” World Journal of Gastroenterology, vol. 13, no. 48, pp. 6470–6477, 2007. View at: Publisher Site | Google Scholar
  52. J. D. Lambeth, “NOX enzymes and the biology of reactive oxygen,” Nature Reviews Immunology, vol. 4, no. 3, pp. 181–189, 2004. View at: Publisher Site | Google Scholar
  53. D. I. Brown and K. K. Griendling, “Nox proteins in signal transduction,” Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1239–1253, 2009. View at: Publisher Site | Google Scholar
  54. J. Mikuła-Pietrasik, A. Kuczmarska, B. Rubiś et al., “Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms,” Free Radical Biology and Medicine, vol. 52, no. 11-12, pp. 2234–2245, 2012. View at: Publisher Site | Google Scholar
  55. P. J. Cook, B. G. Ju, F. Telese, X. Wang, C. K. Glass, and M. G. Rosenfeld, “Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions,” Nature, vol. 458, no. 7238, pp. 591–596, 2009. View at: Publisher Site | Google Scholar
  56. M. J. Zeitz, K. S. Malyavantham, B. Seifert, and R. Berezney, “Matrin 3: chromosomal distribution and protein interactions,” Journal of Cellular Biochemistry, vol. 108, no. 1, pp. 125–133, 2009. View at: Publisher Site | Google Scholar
  57. G. M. Bokoch, B. Diebold, J.-S. Kim, and D. Gianni, “Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases,” Antioxidants and Redox Signaling, vol. 11, no. 10, pp. 2429–2441, 2009. View at: Publisher Site | Google Scholar

Copyright © 2013 Marianna Guida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.